The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Abstract

Objective:

Substance abuse, particularly among homeless youths, is a significant public health challenge in the United States. Detailed data about health care utilization resulting from this preventable behavior remain sparse. This study aimed to compare health care utilization rates related to substance abuse among homeless and nonhomeless youths.

Methods:

A secondary data analysis evaluated records of homeless and nonhomeless patients under age 25 with a primary diagnosis of substance abuse, identified in 2013 and 2014 New York Statewide Inpatient and Emergency Department (ED) Databases. Outcomes included ED visit rate, hospitalization rate, in-hospital mortality, cost, length of stay (LOS), intensive care unit (ICU) utilization, and revisit or readmission rate. Multivariable regression models with a year fixed effect and facility random effect were used to evaluate the association between homelessness and each outcome.

Results:

A total of 68,867 cases included hospitalization or an ED visit related to substance abuse (68,118 nonhomeless and 749 homeless cases). Rates of ED visits related to substance abuse were 9.38 and 4.96, while rates of hospitalizations related to substance abuse were 10.53 and 1.01 per 1,000 homeless and nonhomeless youths, respectively. Homeless patients were more likely to utilize and revisit the ICU, be hospitalized or readmitted, incur higher costs, and have longer LOS than nonhomeless youths (all p<0.01).

Conclusions:

The hospitalization and ED visit rates related to substance abuse were 10 and two times higher among homeless youths compared with nonhomeless youths, respectively. Detailed observation is needed to clarify whether homeless youths receive high-quality care for substance abuse when necessary.

HIGHLIGHTS

  • Among youths in New York in 2013 and 2014, nearly 25% of hospitalizations or emergency department visits related to substance abuse were opioid related and more than 50% were alcohol related.

  • Alcohol was the most common substance used among patients ages 10 to 14 in both homeless and nonhomeless populations.

  • Opioid use increased with age within both populations.

  • Compared with nonhomeless patients, health care utilization related to substance abuse by homeless patients was more likely to be opioid related and less likely to be alcohol related.

Substance abuse among youths is one of the most significant public health challenges in the United States. The 2017 National Survey on Drug Use and Health found that 21.9% of adolescents ages 12 to 17 reported past-year alcohol use and 16.3% reported past-year illicit drug use (1). Substance abuse during adolescence has been linked to negative outcomes, such as dropping out of school, suicide, risky sexual behavior, and underemployment (25).

Homeless youths are uniquely vulnerable to a variety of health problems, including those related to substance abuse (6). In 2018, more than 552,000 people in the United States experienced homelessness, including approximately 111,000 individuals under age 18 and 48,000 ages 18 to 24. Substantially higher substance abuse has been reported among homeless youths (7, 8), compared with housed youths (9, 10). Widespread substance abuse in this population is particularly concerning given that it is a major cause of death among homeless youths (11).

Although disproportionately higher substance abuse among homeless youths is well documented, detailed data about health care utilization resulting from this risky behavior among homeless youths remain sparse. Characteristics of health care utilization have been used as a proxy for overall health and well-being of patients with health conditions in general (1214).

This study evaluated health care utilization related to substance abuse among homeless youths and assessed differences in basic characteristics of health care utilization related to substance abuse between homeless and nonhomeless youths. We hypothesized that health care utilization among homeless youths is higher than among nonhomeless youths.

Methods

Data Source

We used 2013–2014 discharge data from the New York State Inpatient Database (SID) and State Emergency Department Database (SEDD) from the Healthcare Cost and Utilization Project (HCUP), which is part of the Agency for Healthcare Research and Quality. The two data sets contain identical variables necessary for this study and were linked by using the patient’s ID number (VisitLink variable) and year of admission. At the time of the analyses, 2016 data were the most recent available, but because of the mandatory transition to ICD-10-CM on October 1, 2015, and a lack of validated diagnosis codes for substance abuse, we used patient records from 2013 to 2014. New York was selected because it represents almost 20% of the homeless youth population in the United States (15, 16).

Identification of Patients

Emergency department (ED) visits and hospitalizations related to substance abuse for patients ages ≤24 were included because homeless population estimates within this age range were publicly available (15, 17) and there is a well-documented peak in substance abuse in the early 20s (1820). ICD-9-CM codes were used to identify patients with a diagnosis of a substance use disorder on the basis of categorization in a previous publication that included alcohol- and drug-induced disorders, dependence, poisoning, abuse, and withdrawal (21). For patients with a primary diagnosis of these substance use disorders, we looked at secondary diagnosis codes to identify substance type, as previously done (21). Homelessness is a variable available in the databases. We defined patients with a New York numeric zip code as nonhomeless. The institutional review board at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center approved this study.

Data Analysis

We calculated hospitalization and ED visit rates as the number of hospitalizations or ED visits per 1,000 population by using homeless population estimates from the Continuum of Care Homeless Populations and Subpopulations reports issued by the U.S. Department of Housing and Urban Development (HUD) (15, 17). These reports provide demographic data and the number of homeless individuals in New York. (A detailed breakdown of the annual population of homeless youths is presented in a table as an online supplement to this article.) Corresponding population estimates for nonhomeless youths were obtained from the U.S. Census Bureau (22). ED visits and admissions analyses stratified by ages <18 and ≥18 and by opioid related or not were performed in response to the growing opioid epidemic in the United States (2325).

The primary predictor of interest was homelessness. Outcomes of interest included in-hospital mortality, opioid-related admission, cost of ED visit or hospitalization, length of stay (LOS), intensive care unit (ICU) utilization, and ED revisit or hospital readmission. Encrypted personal identifiers provided by HCUP allowed us to track sequential visits for a patient across facilities, including inpatient and ED settings within the same calendar year, but not across calendar years. Therefore, we included only individuals discharged from an ED or hospital between January and June and evaluated their ED revisit or readmission within 6 months after discharge. Due to low death rates, ED mortality was not assessed.

To estimate health care utilization costs, we multiplied total hospital charges with HCUP hospital-level cost-to-charge ratios (26). To account for inflation, cost values were converted to 2015 U.S. dollars by using the medical care component of the Consumer Price Index (27).

Other variables of interest included age, race-ethnicity, insurance type, mental disorders, and year. Race-ethnicity was defined as non-Hispanic White, non-Hispanic Black, Hispanic, and other, and insurance type was categorized as public, private, self-pay, and other form of insurance. The category self-pay likely encompassed those with no insurance. Mental disorder diagnoses were identified by Clinical Classification Software (CCS) codes 650–659, 662, 663, or 670 (see table in online supplement for details). CCS code 663 includes substance abuse; therefore, CCS codes of 663 without a code for substance abuse were included in this category (28).

Descriptive statistics were tabulated and compared between homeless and nonhomeless youths. The type of substance used was examined across age groups and hospital settings (ED versus inpatient).

Logistic regression was used to assess in-hospital mortality, opioid-related admissions, ICU utilization, and ED revisits or readmissions. Linear regression was used to assess health care utilization costs after log-transformation of cost. Negative binomial regression was used to assess LOS. All models incorporated a year fixed effect and a hospital or ED random effect. Additionally, discharge against medical advice was included as a covariate for in-hospital mortality, ICU use, cost, and LOS models because it could affect each of these outcomes. All analyses used SAS, version 9.4. A two-sided p<0.05 was considered statistically significant.

Sensitivity Analyses

To check the robustness of our results, two sensitivity analyses were conducted. First, stratified analyses by opioid use for ICU utilization were performed because ICU utilization was possibly driven by use of opioids. Second, we repeated the main analyses with only patients under age 18 included.

Results

We identified a total of 68,867 cases in which individuals visited the ED or were hospitalized for substance abuse in New York between 2013 and 2014. Among those, 749 cases involved individuals who were homeless, and 68,118 involved individuals who were nonhomeless. Nearly 25% of these cases were opioid related, and more than 50% were alcohol related.

Compared with nonhomeless patients, homeless patients were less likely to be discharged from the ED (p<0.01) (Table 1). Health care utilization by homeless patients was more likely to be opioid related and less likely to be alcohol related, compared with health care utilization by nonhomeless patients (p<0.01). Compared with nonhomeless patients, homeless patients were significantly older; less likely to be White; more likely to be male; more likely to list public insurance; and less likely to list self-pay (all p<0.01).

TABLE 1. Health care utilization related to substance abuse among homeless and nonhomeless youths in New York, 2013–2014a

Total (N=68,867)Nonhomeless (N=68,118)Homeless (N=749)b
VariableN%N%N%p
Emergency department (ED) visit and discharged55,53580.655,47381.4628.3<.01
Hospitalization13,33219.412,64518.668791.7<.01
 Cost ($)
  Median701.53 692.04 3,113.95 <.01
  Interquartile range1,085.721,058.462,676.90
 Length of stay (days)<.01
  Median0.003.00
  Interquartile range1.001.005.00
 Intensive care unit utilization642.9618.9243.2<.01
 Discharged against medical advice3,9305.73,7735.515721.0<.01
ED was admission source61,75789.761,14789.861081.4<.01
Died in hospital or ED37.1>10≤10.34
Substance
 Opioid related16,90024.516,55224.334846.5<.01
 Other substance
  Alcohol36,89953.636,73453.916522.0<.01
  Amphetamine279.4>10≤10.58
  Cannabis (marijuana)4,3776.44,2806.39713.0<.01
  Cocaine9121.3>10>10.10
  Hallucinogen1,0051.59711.4344.5<.01
  Sedative629.9601.9283.7<.01
  Other6,4169.36,3769.4405.3<.01
Age
 Mean±SD20.55±2.9320.54±2.9321.37±2.59<.01
 Median 21.0021.0022.00<.01
 Interquartile range4.004.003.00
Age group
 0–9344.5>10≤10.36
 10–141,3562.0>10≤10.21
 15–177,12410.37,08110.4435.7<.01
 ≥1860,04187.259,34787.169492.7<.01
Race-ethnicity
 Non-Hispanic White38,53956.038,23756.130240.3<.01
 Non-Hispanic Black8,94113.08,78512.915620.8<.01
 Hispanic9,94814.49,76714.318124.2<.01
 Other11,43516.611,32516.611014.7<.01
Sex
 Female26,47538.426,25338.522229.6<.01
 Male42,38761.541,86061.552770.4
Insurance
 Public21,93431.821,24431.269092.1<.01
 Private27,00039.2>10>10<.01
 Self-pay18,32226.618,29926.9233.1<.01
 Other1,6112.3>10≤10<.01
Mental disorder diagnosis21,24730.920,89530.735247.0<.01
Year
 201334,38849.934,09450.129439.3<.01
 201434,47950.134,02450.045560.8<.01

aGroups with 10 or fewer cases are not reported in order to protect the identities of youths in these subgroups.

bSome numbers are masked to prevent estimation of subgroups in neighboring cells with 10 or fewer cases.

TABLE 1. Health care utilization related to substance abuse among homeless and nonhomeless youths in New York, 2013–2014a

Enlarge table

Homeless patients had substantially higher rates of ED visits and hospitalizations related to substance abuse (11.48/1,000), compared with nonhomeless youths (5.43/1,000). (Table 2). This difference was primarily driven by greater hospitalization rates among homeless youths ages 18 to 24 (64.48/1,000) versus nonhomeless youths (3.04/1,000). Stratified analyses for opioid-related health care utilization indicated that non–opioid-related hospitalization among patients ages 18 to 24 was more prominent with homeless youths (31.32/1,000) than nonhomeless youths (1.07/1,000).

TABLE 2. Incidence rate of health care utilization related to substance abuse per 1,000 homeless and nonhomeless youths in New York, 2013–2014

Age
Total<1818–24
VariableaHomelessNonhomelesspHomelessNonhomelesspHomelessNonhomelessp
Total11.485.43<.01.991.02.8170.5814.92<.01
 ED visits9.384.96<.01.741.00.0558.0713.49<.01
 Hospitalizations10.531.01<.01.96.06<.0164.483.04<.01
Opioid related
 Total5.331.32<.01≤10b.07>.9935.094.01<.01
  ED visits4.081.01<.01≤10b.06>.9926.753.06<.01
  Hospitalizations5.04.64<.01≤10b.02.1133.151.97<.01
Other substance
 Total5.303.95<.01.69.94.05131.3210.91<.01
  ED visits5.303.95<.01.69.94.05131.3210.43<.01
  Hospitalizations5.49.37<.01.90.04<.0131.321.07<.01

aTotal includes emergency department (ED) visit and hospitalization rate. ED visits include patients who were discharged directly home and patients who were hospitalized after an ED visit.

bRates with 10 or fewer cases are not reported in order to protect the identities of youths in these subgroups.

TABLE 2. Incidence rate of health care utilization related to substance abuse per 1,000 homeless and nonhomeless youths in New York, 2013–2014

Enlarge table

Of all health care utilization related to substance abuse, opioid- and alcohol-related health care utilization were the most common (Table 3). Among patients ages 10 to 14 in both populations, alcohol was the primary substance involved in health care utilization. Opioid use increased with age among all youths, although alcohol remained the most common substance driving health care utilization among nonhomeless youths in the oldest age group. Stratified analyses by hospital setting showed that opioid use among homeless youths and alcohol use among nonhomeless youths were the most common substance-related drivers to ED visits, whereas opioid use drove the most substance-related hospitalizations for both homeless and nonhomeless youths.

TABLE 3. Substances ranked by association with substance-related emergency department (ED) visits and hospitalizations among homeless and nonhomeless youths in New York, by age group, 2013–2014a

Most common substanceSecond most common substanceThird most common substance
GroupSubstanceN%pSubstanceN%pSubstanceN%p
Total
Overall
 HomelessOpioids34846.5<.01Alcohol16522.0<.01Marijuana9713.0<.01
 NonhomelessAlcohol36,73453.9<.01Opioids16,55224.3<.01Other6,3769.4<.01
Age 0–9
 HomelessCocaineb≤10.04Hallucinogensb≤10<.01NA
 NonhomelessOpioids14742.9<.01Alcohol9728.3<.01Unidentified339.6
Age 10–14
 HomelessAlcohol≤10<.01Opioidsb≤10<.01Hallucinogensb≤10<.01
 NonhomelessAlcohol71052.7<.01Marijuana34025.2<.01Other13510.0<.01
Age 15–17
 HomelessMarijuana1534.9<.01Alcohol>10<.01Hallucinogens≤10<.01
 NonhomelessAlcohol4,39562.0<.01Marijuana1,08315.3<.01Other73710.4<.01
Age 18–24
 HomelessOpioids34549.7<.01Alcohol15021.6<.01Marijuana8111.7<.01
 NonhomelessAlcohol31,53253.1<.01Opioids15,96226.9<.01Other5,4929.3<.01
ED visitsc
Overall
 HomelessOpioids26643.5.24Alcohol13822.6.12Marijuana8413.7.97
 NonhomelessAlcohol35,82257.5.12Opioids12,69320.4.24Other6,0359.7.94
Age 0–9
 HomelessHallucinogens≤10.08NANA
 NonhomelessOpioids13342.0.24Alcohol9229.0.12Unidentified319.8
Age 10–14
 HomelessAlcohol≤10.12Opioidsb≤10.24Hallucinogensb≤10.08
 NonhomelessAlcohol70853.3.12Marijuana34025.6.97Other13510.2.94
Age 15–17
 HomelessAlcoholb≤10.12Marijuanab≤10.97Hallucinogens≤10.08
 NonhomelessAlcohol4,36962.7.12Marijuana1,06615.3.97Other72410.4.94
Age 18–24
 HomelessOpioids26346.1.24Alcohol12521.9.12Marijuana7513.1.97
 NonhomelessAlcohol30,65357.1.12Opioids12,16522.6.24Other5,1659.6.94
Hospitalizations
Overall
 HomelessOpioids32947.9<.01Alcohol13719.9.06Marijuana9313.5.88
 NonhomelessOpioids8,01863.4<.01Alcohol2,30418.2.06Other6466.0.42
Age 0–9
 HomelessCocaineb≤10.53Hallucinogensb≤10<.01NA
 NonhomelessOpioids4159.4<.01Unidentified1217.4Alcohol≤10.06
Age 10–14
 HomelessAlcohol≤10.06Opioids≤10<.01Hallucinogensb≤10<.01
 NonhomelessAlcohol2530.9.06Opioids2024.7<.01Marijuana1518.5.88
Age 15–17
 HomelessMarijuana>10.88Alcohol≤10.06Hallucinogens≤10<.01
 NonhomelessAlcohol12231.7.06Opioids11128.8<.01Marijuana5915.3.88
Age 18–24
 HomelessOpioids32651.4<.01Alcohol12419.6.06Marijuana7712.2.88
 NonhomelessOpioids7,84564.8<.01Alcohol2,15017.8.06Marijuana6895.7.88

aGroups with 10 or fewer cases not reported to protect the identities of youths in these subgroups. Some numbers are masked to prevent estimation of subgroups in neighboring cells with 10 or fewer cases. NA, not applicable because zero cases were identified.

bIndicates substances were equally ranked (i.e., the same number of cases were identified for each substance).

cED visits include patients who were discharged directly home and patients who were hospitalized after an ED visit.

TABLE 3. Substances ranked by association with substance-related emergency department (ED) visits and hospitalizations among homeless and nonhomeless youths in New York, by age group, 2013–2014a

Enlarge table

Adjusting for age, race-ethnicity, insurance type, and discharge against medical advice with year fixed effect and a hospital or ED random effect, regression results showed that, compared with nonhomeless youths, homeless youths had significantly higher costs for ED visits or hospitalizations (cost estimate=3.47) and longer LOS (incidence rate ratio=4.02) (Table 4). Homeless patients were significantly more likely than nonhomeless patients to be admitted to the ICU during hospitalization (odds ratio [OR]=4.75) and more likely to be readmitted to the hospital or to revisit the ED (OR=1.41).

TABLE 4. Results of regression models to evaluate the association between homelessness and study outcomes among homeless and nonhomeless youths with substance-related health care utilizationa

VariableEstimate95% CIp
Homeless in-hospital mortalityb,c3.13.36–26.99.30
Homeless opioid-related utilizationb.95.78–1.17.66
Homeless total costc,d3.473.23–3.71<.01
Homeless length of staye4.023.29–4.94<.01
Homeless intensive care unit utilizationb,c4.752.84–7.93<.01
Homeless readmission or ED revisitb,c,f1.411.04–1.91.03

aReference group for all comparisons: nonhomeless. Models were adjusted by age, race-ethnicity, insurance type, and mental disorder diagnosis, with year fixed effect and a hospital or emergency department (ED) random effect.

bLogistic regression models were used.

cDischarged against medical advice was added to the model as a covariate.

dLinear regression was used after log-transformation of cost.

eNegative binomial regression was used.

fOnly patients who had personal identifiers were included in the model.

TABLE 4. Results of regression models to evaluate the association between homelessness and study outcomes among homeless and nonhomeless youths with substance-related health care utilizationa

Enlarge table

Because the sample size was reduced in the stratified sensitivity analyses, one model that included only patients with opioid-related health care utilization did not detect significant differences in ICU utilization between homeless and nonhomeless patients. However, the direction of the point estimate did not change. This indicated a higher likelihood of ICU utilization among homeless patients compared with nonhomeless patients, regardless of opioid use (see table in online supplement). Results of analyses including only patients ages <18 mirrored the original analyses (see table in online supplement).

Discussion

Using the SID and SEDD from New York, this study demonstrated different characteristics of health care utilization, represented by hospitalizations and ED visits related to substance abuse among homeless and nonhomeless youths. We found that the rate of ED visits related to substance abuse was almost two times higher among homeless youths, compared with nonhomeless youths, and the hospitalization rate related to substance abuse was more than 10 times higher. This difference was mainly driven by a greater rate of non–opioid-related hospitalizations among homeless youths, especially among those ages 18 to 24.

Health care utilization could be used as a proxy for population well-being. For example, it could represent heavy substance abuse, because heavy use is more likely than casual use to result in health care utilization. However, differences in heavy use between homeless and nonhomeless youths could be greater in magnitude than the differences observed in this study because of disparities in access to care. Homeless youths face obstacles to receiving medical care, including a shortage of medical services in poor communities (29), lack of transportation, and social isolation. Our study showed that only 8.3% of homeless patients were directly discharged from the ED, whereas 81.4% of nonhomeless patients were directly discharged from the ED. Additionally, compared with nonhomeless youths, homeless youths had significantly higher ICU utilization, indicating that they did not utilize health care until their condition became severe.

Our models detected higher health care utilization cost and longer LOS among homeless youths, compared with nonhomeless youths. Health care cost and LOS are typically used as a proxy for severity. Specifically, if the condition is severe, the patient will require additional treatment, which will result in high costs and a long LOS. However, studies of patients experiencing homelessness have reported a pattern of a longer average LOS possibly not related to the severity of their condition, compared with their housed counterparts (30, 31). Some doctors may refrain from discharging a patient until a shelter or other more stable form of housing is arranged (30, 31). Therefore, our finding that homelessness was associated with higher costs and longer LOS does not necessarily mean that homeless youths experienced more severe medical conditions than nonhomeless patients, but their greater utilization of the ICU suggests that homeless patients did not utilize health care until their condition became severe (32). Detailed observations are needed to clarify whether homeless youths receive medical care for substance abuse when needed.

We demonstrated that, compared with nonhomeless patients, homeless patients were more likely to revisit the ED or be readmitted to the hospital. Several studies have cited high readmission rates and longer LOS among homeless individuals, compared with nonhomeless individuals (30, 33). Both factors are largely affected by care transitions. If the individual does not have a suitable place to recover after discharge, the physician may be incentivized to keep the individual in the hospital until coordination with a shelter or other care has been established (30). If the recovering patient is released to the streets or unstable housing, the patient’s condition will likely worsen, and he or she will likely return to the ED or hospital within 30 days of discharge (30, 33). Previous studies have reported high substance abuse rates among homeless youths, compared with nonhomeless youths (710), and developing programs to reduce substance abuse among homeless youths is particularly important. ED visits and admissions could be a good opportunity to provide prevention and education programs to these young homeless patients who would otherwise be difficult to identify and contact. Ensuring that these programs are available during their first visit to the hospital for substance abuse may help reduce the revisit and readmission rate as well as the mortality rate.

The opioid-related health care utilization rate among homeless patients ages 18 to 24 was much higher than the rate among their nonhomeless counterparts. Specifically, the opioid-related hospitalization rate among homeless patients was almost 17 times higher than the rate among nonhomeless patients in this age group. This result is consistent with previous studies for adults ages 18 and older (3436). The magnitude of difference in the hospitalization rate was even greater for non–opioid-related hospitalizations. Alcohol accounted for the largest percentage of non–opioid-related ED visits and hospitalizations related to substance abuse, necessitating immediate prevention measures and education related to alcohol abuse among homeless youths.

Several limitations should be acknowledged. First, although 20% of homeless youths in the United States reside in New York, the results may not be generalizable to other parts of the country. New York provides various means of support to its homeless citizens, with 96.8% of those in our study utilizing public or private insurance—a likely result of the transition, beginning in 2012, into Medicaid managed care (37) by the state’s Office of Insurance Programs. Because New York law requires shelter for all who request it, 99% of youths ages 0–24 in New York were sheltered in 2013, contrasted with only 79% nationally (17, 38). Although we included only a single state in our analyses, our findings are novel because health care utilization due to substance abuse among homeless youths has not previously been reliably assessed.

Second, this study is a serial cross-sectional analysis of an administrative database, and causality between health care utilization related to substance abuse and housing instability is difficult to establish. Additionally, the database lacks clinical detail beyond ICD-9-CM codes, and only patients who visited the ED or were hospitalized were included in the study. The 2013 National Survey on Drug Use and Health reported that only 10.9% of individuals ages 12 and older, including adults, who needed treatment for illicit drug or alcohol abuse received treatment (39). As a result, rates of ED visits and hospitalizations from this study could, therefore, be underestimated when used as a proxy for needed substance abuse care. Rates of ED visits and hospitalizations related to substance abuse from this study may also be biased because of the quality of coding. However, a previous study found that ICD-9-CM coding accuracy for opioid overdose was high (40). We used the primary diagnosis code to identify the primary reason for health service utilization, as previously practiced. Song (41) argued that the primary diagnosis code reflects the physician’s professional opinion as to the primary cause of admission. We believe our method identified health service utilization related to substance abuse as the primary condition; however, it is still possible that substance abuse was secondary to another condition.

Third, the quality of coding for homelessness is unknown. For example, some patients or medical staff may report a shelter zip code as the zip code of residence, some patients may choose not to disclose their living status for fear of being stigmatized, and some health care facilities do not code homeless status (42). Health care staff familiar with patients who frequently utilize services, especially those with behavioral conditions such as substance abuse, may be more likely to accurately list housing insecurity as a result of recurrent interactions with such patients. Therefore, our results indicating that those experiencing homelessness were more likely to revisit health care facilities could be a result of reverse causation (i.e., individuals who were more likely to revisit health care facilities were more likely to be coded as homeless).

Fourth, estimates of the homeless population based on point-in-time counts of sheltered and unsheltered persons are likely to be conservative because of the transient nature of homelessness. Nonsheltered youths may be a particularly undercounted population, because they may be out of sight during the counts (43). In 2014, children and youths represented less than 1% of New York’s total counted unsheltered homeless population (15). Given that most homeless children and youths in New York are sheltered, they are less likely than other homeless groups to be undercounted. Despite the biases discussed, these counts are the best estimates available. Each city’s homeless coalition provides HUD with local counts to ensure properly allocated federal funding for programs and services aimed at assisting those experiencing homelessness (44).

Fifth, all primary analyses were conducted at the level of the ED visit or the hospital admission, with each visit or admission included as a unique observation. The personal identifiers provided in the HCUP databases allow only for tracking of patient revisits and readmissions within a given data year. Because of this limitation, we were unable to conduct analyses at the patient level, and patients who were discharged and subsequently revisited or were readmitted may have been double-counted.

Sixth, ED and hospitalization rates for those ages 0–9 most likely are not representative of substance abuse by infants or children. It is more likely that substances were passed through breast milk or accidentally ingested (45, 46).

Last, number of deaths due to opioid overdose increased steadily in 2013 (47). Our study period reflected only 2 years after the onset of this particular wave of the opioid epidemic. Further evaluation with additional years of data is needed.

Conclusions

This study demonstrated that, compared with nonhomeless youths, homeless youths experienced much higher rates of health care utilization related to substance abuse. Higher ICU utilization among homeless youths versus nonhomeless youths indicated that homeless youths did not utilize services until their condition had become severe. Detailed observation is needed to clarify whether homeless youths receive high-quality care for substance abuse when necessary.

The Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California (all authors); Department of Pediatrics, David Geffen School of Medicine, Harbor-UCLA Medical Center, Torrance, California (Sakai-Bizmark, Smith).
Send correspondence to Dr. Sakai-Bizmark ().

The work of Dr. Sakai-Bizmark is funded by the National Institutes of Health Research Scientist Development award (NHLBI K01141697). This study utilized 2013–2014 discharge data from the New York State Inpatient Database (www.hcup-us.ahrq.gov/sidoverview.jsp) and State Emergency Department Database (www.hcup-us.ahrq.gov/seddoverview.jsp) from the Healthcare Cost and Utilization Project, part of the Agency for Healthcare Research and Quality (https://www.hcup-us.ahrq.gov/db/hcupdatapartners.jsp).

The authors report no financial relationships with commercial interests.

References

1 Results From the 2017 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality, 2018. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHDetailedTabs2017/NSDUHDetailedTabs2017.pdfGoogle Scholar

2 Squeglia LM, Jacobus J, Tapert SF: The influence of substance use on adolescent brain development. Clin EEG Neurosci 2009; 40:31–38Crossref, MedlineGoogle Scholar

3 Guerri C, Pascual M: Mechanisms involved in the neurotoxic, cognitive, and neurobehavioral effects of alcohol consumption during adolescence. Alcohol 2010; 44:15–26Crossref, MedlineGoogle Scholar

4 Winward JL, Hanson KL, Tapert SF, et al.: Heavy alcohol use, marijuana use, and concomitant use by adolescents are associated with unique and shared cognitive decrements. J Int Neuropsychol Soc 2014; 20:784–795Crossref, MedlineGoogle Scholar

5 Johnson PB, Boles SM, Kleber HD: The relationship between adolescent smoking and drinking and likelihood estimates of illicit drug use. J Addict Dis 2000; 19:75–81Crossref, MedlineGoogle Scholar

6 Hendee WR: Health care needs of homeless and runaway youths. JAMA 1989; 262:1358–1361Crossref, MedlineGoogle Scholar

7 Baer JS, Ginzler JA, Peterson PL: DSM-IV alcohol and substance abuse and dependence in homeless youth. J Stud Alcohol 2003; 64:5–14Crossref, MedlineGoogle Scholar

8 Rosenthal D, Mallett S, Milburn N, et al.: Drug use among homeless young people in Los Angeles and Melbourne. J Adolesc Health 2008; 43:296–305Crossref, MedlineGoogle Scholar

9 Kann L, McManus T, Harris WA, et al.: Youth Risk Behavior Surveillance—United States, 2015. MMWR Surveill Summ 2016; 65:1–174Google Scholar

10 Miech RA, Schulenberg JE, Johnston LD, et al.: National Adolescent Drug Trends in 2018. Ann Arbor, MI, Monitoring the Future, 2018. http://www.monitoringthefuture.org/data/18data/18drtbl1.pdfGoogle Scholar

11 Roy E, Haley N, Leclerc P, et al.: Mortality in a cohort of street youth in Montreal. JAMA 2004; 292:569–574Crossref, MedlineGoogle Scholar

12 Hasegawa K, Tsugawa Y, Brown DFM, et al.: Childhood asthma hospitalizations in the United States, 2000–2009. J Pediatr 2013; 163:1127–1133.e3Crossref, MedlineGoogle Scholar

13 Hasegawa K, Tsugawa Y, Brown DFM, et al.: Trends in bronchiolitis hospitalizations in the United States, 2000–2009. Pediatrics 2013; 132:28–36Crossref, MedlineGoogle Scholar

14 Nandi D, Lin KY, O’Connor MJ, et al.: Hospital charges for pediatric heart failure–related hospitalizations from 2000 to 2009. Pediatr Cardiol 2016; 37:512–518Crossref, MedlineGoogle Scholar

15 HUD's 2014 Continuum of Care Homeless Assistance Programs: Homeless Populations and Subpopulations: New York. Washington, DC, US Department of Housing and Urban Development, 2014. https://files.hudexchange.info/reports/published/CoC_PopSub_State_NY_2014.pdfGoogle Scholar

16 HUD’s 2014 Continuum of Care Homeless Assistance Programs: Homeless Populations and Subpopulations: All States, Territories, Puerto Rico, and District of Columbia. Washington, DC, US Department of Housing and Urban Development, 2014. https://files.hudexchange.info/reports/published/CoC_PopSub_NatlTerrDC_2014.pdfGoogle Scholar

17 HUD's 2013 Continuum of Care Homeless Assistance Programs: Homeless Populations and Subpopulations: New York. Washington, DC, US Department of Housing and Urban Development, 2013. https://files.hudexchange.info/reports/published/CoC_PopSub_State_NY_2013.pdfGoogle Scholar

18 Park MJ, Paul Mulye T, Adams SH, et al.: The health status of young adults in the United States. J Adolesc Health 2006; 39:305–317Crossref, MedlineGoogle Scholar

19 Peiper NC, Ridenour TA, Hochwalt B, et al.: Overview on prevalence and recent trends in adolescent substance use and abuse. Child Adolesc Psychiatr Clin N Am 2016; 25:349–365Crossref, MedlineGoogle Scholar

20 Merrin GJ, Thompson K, Leadbeater BJ: Transitions in the use of multiple substances from adolescence to young adulthood. Drug Alcohol Depend 2018; 189:147–153Crossref, MedlineGoogle Scholar

21 Heslin KC, Elixhauser A, Steiner CA: Hospitalizations Involving Mental and Substance Use Disorders Among Adults, 2012. HCUP Statistical Brief 191. Rockville, MD, Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project, 2006Google Scholar

22 Explore Census Data. Washington, DC, US Census Bureau, 2020. https://data.census.gov/cedsci. Accessed June 29, 2020Google Scholar

23 Rudd RA, Seth P, David F, et al.: Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. MMWR Morb Mortal Wkly Rep 2016; 65:1445–1452Crossref, MedlineGoogle Scholar

24 Overdose Death Rates. Bethesda, MD, National Institute on Drug Abuse, 2019. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates. Accessed April 29, 2019Google Scholar

25 Rossen L, Bastian B, Warner M, et al: Drug Poisoning Mortality: United States, 1999–2017. Hyattsville, MD, National Center for Health Statistics, 2019. https://www.cdc.gov/nchs/data-visualization/drug-poisoning-mortality/index.htm. Accessed April 29, 2019Google Scholar

26 Cost-to-Charge Ratio Files. Rockville, MD, Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project, 2017. https://www.hcup-us.ahrq.gov/db/state/costtocharge.jsp. Accessed June 23, 2017Google Scholar

27 Consumer Price Index. Washington, DC, US Department of Labor, Bureau of Labor Statistics, 2015. http://www.bls.gov/cpi/home.htm. Accessed May 8, 2015Google Scholar

28 Heslin KC, Elixhauser A: Mental and Substance Use Disorders Among Hospitalized Teenagers. HCUP Statistical Brief 202. Rockville, MD, Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project 2016. https://www.ncbi.nlm.nih.gov/books/NBK367628/table/sb202.t5. Accessed March 9, 2020Google Scholar

29 Alegria M, Carson NJ, Goncalves M, et al.: Disparities in treatment for substance use disorders and co-occurring disorders for ethnic/racial minority youth. J Am Acad Child Adolesc Psychiatry 2011; 50:22–31Crossref, MedlineGoogle Scholar

30 Salit SA, Kuhn EM, Hartz AJ, et al.: Hospitalization costs associated with homelessness in New York City. N Engl J Med 1998; 338:1734–1740Crossref, MedlineGoogle Scholar

31 Wadhera RK, Choi E, Shen C, et al.: Trends, causes, and outcomes of hospitalizations for homeless individuals: a retrospective cohort study. Med Care 2019; 57:21–27Crossref, MedlineGoogle Scholar

32 Recent Trends in Mortality Rates and Causes of Death Among People Experiencing Homelessness in Los Angeles County. Los Angeles, Los Angeles County Department of Public Health, Center for Health Impact Evaluation, 2019Google Scholar

33 Doran KM, Ragins KT, Iacomacci AL, et al.: The revolving hospital door: hospital readmissions among patients who are homeless. Med Care 2013; 51:767–773Crossref, MedlineGoogle Scholar

34 Yamamoto A, Needleman J, Gelberg L, et al.: Association between homelessness and opioid overdose and opioid-related hospital admissions/emergency department visits. Soc Sci Med. 2019;242:112585Crossref, MedlineGoogle Scholar

35 Baggett TP, Hwang SW, O’Connell JJ, et al.: Mortality among homeless adults in Boston: shifts in causes of death over a 15-year period. JAMA Intern Med 2013; 173:189–195Crossref, MedlineGoogle Scholar

36 Marshall JR, Gassner SF, Anderson CL, et al.: Socioeconomic and geographical disparities in prescription and illicit opioid-related overdose deaths in Orange County, California, from 2010–2014. Subst Abus 2019; 40:80–86Crossref, MedlineGoogle Scholar

37 Policy and Guidance to Transition the Homeless Population Into Medicaid Managed Care. Albany, New York State Department of Health, Office of Health Insurance Programs, 2012. https://www.health.ny.gov/health_care/medicaid/redesign/guidance_for_homeless_transition.htmGoogle Scholar

38 HUD’s 2013 Continuum of Care Homeless Assistance Programs: Homeless Populations and Subpopulations: All States, Territories, Puerto Rico, and District of Columbia. Washington, DC, US Department of Housing and Urban Development, 2013. https://files.hudexchange.info/reports/published/CoC_PopSub_NatlTerrDC_2013.pdfGoogle Scholar

39 Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality, 2014. https://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf. Accessed Jan 11, 2019Google Scholar

40 Reardon JM, Harmon KJ, Schult GC, et al.: Use of diagnosis codes for detection of clinically significant opioid poisoning in the emergency department: a retrospective analysis of a surveillance case definition. BMC Emerg Med 2016; 16:11Crossref, MedlineGoogle Scholar

41 Song Z: Mortality quadrupled among opioid-driven hospitalizations, notably within lower-income and disabled white populations. Health Aff 2017; 36:2054–2061CrossrefGoogle Scholar

42 Mackelprang JL, Qiu Q, Rivara FP: Predictors of emergency department visits and inpatient admissions among homeless and unstably housed adolescents and young adults. Med Care 2015; 53:1010–1017Crossref, MedlineGoogle Scholar

43 Hopper K, Shinn M, Laska E, et al.: Estimating numbers of unsheltered homeless people through plant-capture and postcount survey methods. Am J Public Health 2008; 98:1438–1442Crossref, MedlineGoogle Scholar

44 Jarpe M, Mosley JE, Smith BT: Understanding the collaborative planning process in homeless services: networking, advocacy, and local government support may reduce service gaps. J Public Health Manag Pract 2019; 25:262–269Crossref, MedlineGoogle Scholar

45 Tolia VN, Patrick SW, Bennett MM, et al.: Increasing incidence of the neonatal abstinence syndrome in US neonatal ICUs. N Engl J Med 2015; 372:2118–2126Crossref, MedlineGoogle Scholar

46 Lind JN, Petersen EE, Lederer PA, et al.: Infant and maternal characteristics in Neonatal abstinence syndrome—selected hospitals in Florida, 2010–2011. MMWR Morb Mortal Wkly Rep 2015; 64:213–216MedlineGoogle Scholar

47 Opioid Overdose: Understanding the Epidemic. Atlanta, Centers for Disease Control and Prevention, 2018. https://www.cdc.gov/drugoverdose/epidemic/index.htmlGoogle Scholar